TABLE OF CONTENTS
Volume 8, Issue 6 (December 2008)
Review
Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility FREE
A R Hughes, W R Spreen, M Mosteller, L L Warren, E H Lai, C H Brothers, C Cox, A J Nelsen, S Hughes, D E Thorborn, B Stancil, S V Hetherington, D K Burns and A D Roses
Pharmacogenomics J 8: 365-374; advance online publication, March 11, 2008; doi:10.1038/tpj.2008.3
Original Articles
Repeated clomipramine treatment reversed the inhibition of cell proliferation in adult hippocampus induced by chronic unpredictable stress FREE
Q Liu, J Yu, Q-L Mao-Ying, W-L Mi, B Li, Y-Q Wang, J Wang and G-C Wu
Pharmacogenomics J 8: 375-383; advance online publication, January 15, 2008; doi:10.1038/sj.tpj.6500485
Glycogen synthase kinase-3
gene is associated with antidepressant treatment response in Chinese major depressive disorder
S-J Tsai, Y-J Liou, C-J Hong, Y W-Y Yu and T-J Chen
Pharmacogenomics J 8: 384-390; advance online publication, January 15, 2008; doi:10.1038/sj.tpj.6500486
Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment
D F Heitjan, D A Asch, Riju Ray, Margaret Rukstalis, Freda Patterson and C Lerman
Pharmacogenomics J 8: 391-399; advance online publication, March 18, 2008; doi:10.1038/sj.tpj.6500492
Interaction between polymorphisms in the renin–angiotensin–system and angiotensin-converting enzyme inhibitor or 
-blocker use and the risk of myocardial infarction and stroke
H Schelleman, O H Klungel, J C M Witteman, M M B Breteler, A Hofman, C M van Duijn, A de Boer and B H Ch Stricker
Pharmacogenomics J 8: 400-407; advance online publication, March 18, 2008; doi:10.1038/sj.tpj.6500493
-Adrenergic receptor gene polymorphisms and hemodynamic response to dobutamine during dobutamine stress echocardiography FREE
C L Aquilante, H N Yarandi, L H Cavallari, T E Andrisin, S G Terra, J F Lewis, K K Hamilton and J A Johnson
Pharmacogenomics J 8: 408-415; advance online publication, February 5, 2008; doi:10.1038/sj.tpj.6500490
CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine FREE
R Kreutz, J Bolbrinker, F van der Sman-de Beer, E W Boeschoten, F W Dekker, S Kain, P Martus, A Sietmann, F Friedrichs, M Stoll, G Offermann and J Beige
Pharmacogenomics J 8: 416-422; advance online publication, January 8, 2008; doi:10.1038/sj.tpj.6500488
